MERZ PHARMA GMBH & CO. KGAA
Patent Owner
Stats
- 55 US PATENTS IN FORCE
- 16 US APPLICATIONS PENDING
- Feb 15, 2018 most recent publication
Details
- 55 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,659 Total Citation Count
- Apr 11, 1990 Earliest Filing
- 106 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0045,733 METHODS FOR THE DETERMINATION OF THE BIOLOGICAL ACTIVITIES OF NEUROTOXIN POLYPEPTIDESNov 20, 15Feb 15, 18[G01N, C07K]
2017/0204,391 METHOD FOR THE MANUFACTURING OF DI-CHAIN PROTEINS FOR USE IN HUMANSMar 20, 17Jul 20, 17[C12N, C07K]
2017/0189,500 USE OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS FOR THE TREATMENT OF PATIENTS HAVING CERTAIN MUSCLE-RELATED DISORDERSJun 12, 15Jul 06, 17[A61K, C12N]
2017/0128,551 NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECTJun 12, 15May 11, 17[A61K]
2017/0119,863 NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECTJun 12, 15May 04, 17[A61K, C12N]
2017/0112,907 NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECTJun 12, 15Apr 27, 17[A61K]
2017/0059,558 GANGLIOSIDES FOR STANDARDIZING AND INCREASING THE SENSITIVITY OF CELLS TO BOTULINUM NEUROTOXINS IN IN VITRO TEST SYSTEMSFeb 18, 15Mar 02, 17[C12N, G01N]
2017/0035,678 COMPOSITION FOR IMPROVING THE APPEARANCE OF AGEING SKINApr 16, 15Feb 09, 17[A61K, A61Q]
2017/0027,885 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COCHLEAR TINNITUSOct 12, 16Feb 02, 17[A61K]
2016/0184,413 FORMULATION FOR STABILIZING PROTEINS, WHICH IS FREE OF MAMMALIAN EXCIPIENTOct 23, 15Jun 30, 16[A61K, C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9827298 Neurotoxins exhibiting shortened biological activityNov 03, 16Nov 28, 17[A61K, C12N, A61Q, C07K]
9822223 Method of preparing a composition based on hyaluronic acidJun 14, 13Nov 21, 17[C08J, A61K, C08L, A61L]
9511114 Neurotoxins exhibiting shortened biological activityOct 19, 15Dec 06, 16[A61K, C12N, A61Q, C07K]
9498450 1-aminocyclohexane derivatives for the treatment of cochlear tinnitusSep 10, 08Nov 22, 16[A61K]
9314514 Modified neurotoxins with poly-glycine and uses thereofNov 08, 12Apr 19, 16[A61K, C12N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0289,731 MEANS AND METHODS FOR DETERMINATION OF BOTULINUM NEUROTOXIN BIOLOGICAL ACTIVITYAbandonedNov 20, 13Oct 06, 16[C12Q, C07K]
2015/0322,118 RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH ENHANCED MEMBRANE LOCALIZATIONAbandonedDec 05, 13Nov 12, 15[C07K]
2015/0232,828 METHOD FOR THE MANUFACTURING OF RECOMBINANT PROTEINS HARBOURING AN N-TERMINAL LYSINEAbandonedAug 20, 13Aug 20, 15[C12N]
2015/0073,008 Topical Application of Vinca Alkaloids for the Treatment of Actinic KeratosisAbandonedSep 11, 14Mar 12, 15[A61K]
2015/0044,709 MEANS AND METHODS FOR DETERMINING NEUROTOXIN ACTIVITY BASED ON A MODIFIED LUCIFERASEAbandonedMar 07, 13Feb 12, 15[C12Q, C12N]
2014/0377,248 METHOD FOR THE MANUFACTURING OF DI-CHAIN PROTEINS FOR USE IN HUMANSAbandonedDec 21, 12Dec 25, 14[A61K, C12N]
2014/0371,260 COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORSAbandonedMay 16, 14Dec 18, 14[A61K]
2014/0357,726 USE OF PEGYLATED ALCOHOLS FOR THE TREATMENT OF ACTINIC KERATOSISAbandonedNov 29, 12Dec 04, 14[A61K]
2014/0303,246 USE OF ADAMANTANE DERIVATIVES FOR THE TREATMENT OF ACTINIC KERATOSISAbandonedSep 07, 12Oct 09, 14[A61K]
2014/0248,332 COMPOSITION COMPRISING AN ONION EXTRACT AND LIPOSOMESAbandonedJun 21, 12Sep 04, 14[A61K]
2014/0228,440 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASESAbandonedMar 20, 14Aug 14, 14[A61K]
2014/0170,133 ALTERATION OF PROTEOLYTIC CLEAVAGE OF BOTULINUM NEUROTOXINSAbandonedJul 26, 12Jun 19, 14[A61K, C12N]
2014/0134,643 MEANS AND METHODS FOR THE DETERMINATION OF THE AMOUNT OF NEUROTOXIN POLYPEPTIDE AND OF ITS CATALYTIC AND PROTEOLYTIC ACTIVITIESAbandonedJan 16, 14May 15, 14[G01N]
2014/0107,212 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF MAST CELL MEDIATED DISEASESAbandonedDec 18, 13Apr 17, 14[A61K]
2013/0331,332 COMPOSITION COMPRISING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMAAbandonedFeb 29, 12Dec 12, 13[A61K, A61Q]
2013/0296,427 NERAMEXANE FOR THE TREATMENT OR PREVENTION OF TINNITUS RELATED WITH STRESS OR ACUTE HEARING LOSSAbandonedJan 19, 12Nov 07, 13[A61K]
2013/0165,522 GEL FORMULATIONS FOR THE TOPICAL USE OF 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVESAbandonedJun 17, 11Jun 27, 13[A61K]
2013/0158,235 SELECTIVE MANUFACTURE OF RECOMBINANT NEUROTOXIN POLYPEPTIDESAbandonedAug 10, 11Jun 20, 13[C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.